Prophylaxis of Chemotherapy-Induced Neutropenia and Febrile Neutropenia with Lipegfilgrastim in 2489 Cancer Patients: Final Results from the Non-Interventional Study NADIR 26. Dezember 2018 Fietz, T., Lück, A., Schulz, H., Harde, J., Losem, C., Grebhardt, S., Wolff, T., Potthoff, K., Müller, U., Zaiss, M., Kurbacher, C.M. Current Medical Research and Opinion, 17. Dezember 2018, 1–27. https://doi.org/10.1080/03007995.2018.1560200. Abstract Exploratory biomarker analysis in patients treated with vinorelbine plus everolimus or vinorelbine monotherapy as second-line treatment for HER2-negative advanced breast cancer: Final results from the randomized phase II trial VicTORia. Decker, T., Mündlein, A., Marschner, N., Welt, A., Riedt, T., Hagen, V., Rauh, J., Klein, D., Potthoff, K., Jähnig, P., Schröder, H., Hegewisch-Becker, S., Lerchenmüller,… Weiterlesen SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11). Retz, M., Bedke, J., Bögemann, M., Grimm, M.-O., Zimmermann, U., Müller, L., Leiber, C., Teber, D., Wirth, M., Bolenz, C., van Alphen, R., De Santis,… Weiterlesen